Sprott Inc’s Medtronic MDT Stock Holding History

Sprott Inc’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-202,600	Closed	-$17.5M	–	185
2016 Q3	$17.5M	Hold	202,600	–	–	0.62%	35
2016 Q2	$17.6M	Sell	202,600 -232,800	-53%	-$18.8M	0.9%	35
2016 Q1	$32.7M	Buy	+435,400	New	+$32.8M	2.56%	10

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sprott Inc's MDT Position: Q3 2017 in Review

Sprott Inc sold out of Medtronic (MDT) in Q3 2017, closing a stake of 4,400 shares — an estimated $390K sold.

Sprott Inc first reported a position in MDT in Q1 2016 and held it in 6 quarters. The position peaked at $54.6M in Q1 2016. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

Sprott Inc reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
Sprott Inc sold 4,400 Medtronic shares in Q3 2017, an estimated $390K.
Sprott Inc first reported a position in Medtronic in Q1 2016 and held it in 6 quarters.
Sprott Inc's Medtronic position peaked at $54.6M in Q1 2016.
1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Sprott Inc's 13F filing for Q3 2017, filed 3 Nov 2017.